Mycophenolate mofetil in dermatomyositis: is it safe?

Neurology. 2006 Apr 25;66(8):1245-7. doi: 10.1212/01.wnl.0000208416.32471.c0.

Abstract

The authors report 10 patients with idiopathic dermatomyositis treated with mycophenolate mofetil in combination with corticosteroids. Successful steroid taper without disease relapse was achieved in six patients; however, in three patients, treatment was associated with opportunistic infections, leading to death in one patient. The disproportionately high rate of opportunistic infections in this group is considered.

MeSH terms

  • Adult
  • Aged
  • Bronchopneumonia / chemically induced
  • Bronchopneumonia / etiology
  • Bronchopneumonia / mortality
  • Dermatomyositis / complications
  • Dermatomyositis / drug therapy*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Mycophenolic Acid / administration & dosage
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Opportunistic Infections / chemically induced
  • Opportunistic Infections / etiology
  • Opportunistic Infections / mortality
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Prednisone